XML 22 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities      
Net income $ 6,125 $ 2,176 $ 8,087
Adjustments to reconcile net income to net cash (used in) provided by operating activities:      
Depreciation and amortization 1,330 1,325 1,345
Net amortization of loans and investment securities 1,708 1,730 1,617
Amortization and net change in mortgage servicing rights valuation   55 55
Provision for loan losses 9,954 670 3,775
Change in fair value of equity securities (9)    
Debt securities gains, net (56) (3) (22)
Impairment write-down on securities recognized in earnings     40
Legal reserve   10,000  
Legal reserve, pay-out (10,000)    
Provision for credit losses on off-balance sheet exposures 2,361    
Loans originated for sale (21,633) (9,887) (8,972)
Proceeds from sale of loans 21,957 9,985 8,893
Write-down on premises and equipment 17 45 69
Write-down of other real estate owned 6 83 1,209
Net loss on sale or disposal of other real estate/other repossessed assets 5 26 31
Increase in cash surrender value of life insurance (515) (521) (531)
Gain from surrender of life insurance policy     (76)
Stock option compensation 185 161 88
Contribution to pension plan (1,000)    
(Increase) decrease in other assets (957) 293 1,174
(Decrease) increase in other liabilities (175) 945 (1,094)
Deferred tax benefit (1) (831) (832)
Net cash provided by operating activities 9,302 16,252 14,856
Cash flows from investing activities      
Proceeds from sales and calls of investment securities available for sale 4,171 1,205 3,825
Proceeds from maturities and pay-downs of securities available for sale 18,665 22,424 25,393
Purchase of investment securities available for sale (30,175) (8,602) (985)
Net decrease (increase) in restricted stock 4 1,311 (16,605)
Net increase in loans (39,083) (49,911) (114,780)
Acquisition of other real estate owned (105)    
Proceeds from sale of other real estate/other repossessed assets 79 2,298 625
Proceeds from surrender of life insurance policy     436
Proceeds from sale of other assets 117 154  
Capital expenditures (1,162) (1,119) (579)
Net cash used in investing activities (47,489) (32,240) (102,670)
Cash flows from financing activities      
Net increase in demand deposits, interest-bearing checking, and savings accounts 49,326 64,225 74,704
Net (decrease) increase in time deposits (13,878) 836 (11,096)
Net (decrease) increase in short-term borrowings   (24,270) 24,270
Dividends paid (4,598) (4,031) (3,523)
Purchase of Treasury shares (88)   (795)
Cash received from option exercises 362 175 82
Common stock issued under dividend reinvestment plan 1,417 991 1,671
Net cash provided by financing activities 32,541 37,926 85,313
(Decrease) increase in cash and cash equivalents (5,646) 21,938 (2,501)
Cash and cash equivalents as of January 1 58,603 36,665 39,166
Cash and cash equivalents as of September 30 52,957 58,603 36,665
Supplemental Disclosures of Cash Flow Information      
Cash paid during the year for: Interest on deposits and other borrowed funds 4,170 2,458 2,253
Cash paid during the year for: Income taxes 250 3,955 2,100
Noncash Activities:      
Loans transferred to Other Real Estate $ 71 $ 90 $ 329